1. Home
  2. ltk asia

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

$ 11.99

4.7 (192) In stock

Department of Thoracic Oncology National Cancer Center Hospital East

Combinatorial tumor suppressor inactivation efficiently initiates

Nature里程碑:非小细胞肺癌新靶点——CLIP1-LTK

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

Division of Cancer Immunology

PDF) Tyrosine Kinase Inhibitors Target B Lymphocytes

IJMS, Free Full-Text

AMG-510 and cisplatin combination increases antitumor effect in

肺癌靶点研究渐露锋芒,源井生物基因编辑细胞助力肿瘤研究_源井生物

Combinatorial tumor suppressor inactivation efficiently initiates

EGFR exon 20 insertion mutations and ERBB2 mutations in lung

2022肺癌靶标热点追击,ERRα/LTK/EMSY初露锋芒-源井生物- 哔哩哔哩